Delineating germline, tumor and extrinsic factors driving mucosal melanoma risk and response
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210975
- Recipient
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $200,510
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Houston, TX 77030, USA
Award details come from USAspending.gov.
About this award
The University of Texas MD Anderson Cancer Center will receive $200,510 under a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research to delineate germline, tumor and extrinsic factors driving mucosal melanoma risk and response. Through September 2025, MD Anderson investigators will work to transform military and public health by investigating medical solutions for the battlefield and innovating impactful melanoma research. As the prime awardee, MD Anderson will collaborate with parent organization the University of Texas System to achieve the grant's goals of advancing basic, applied and advanced biomedical research solutions for service members and all Americans.
Quick answers
Who received award W81XWH2210975?
W81XWH2210975 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210975 worth?
$200,510 has been obligated on W81XWH2210975.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award